Recurrent Thrombotic Events after Catastrophic Antiphopholipid Syndrome
نویسندگان
چکیده
منابع مشابه
Recurrent Thrombotic Events after Catastrophic Antiphopholipid Syndrome
A 40-year-old man was transferred to our hospital in March 1994 for gross hematuria and decreased urine output. The patient exhibited chest pain and shortness of breath 2 weeks prior to the initial visit. These symptoms were relieved without particular management. Fever and chills developed thereafter followed by abdominal pain. The patient visited a local clinic and was managed for acute pancr...
متن کاملInherited Antithrombin Deficiency in Patients with Recurrent Thrombotic Events
Objective: To investigate the frequency of hereditary antithrombin deficiency in patients presenting with recurrent thrombotic events, venous and/or arterial. Material and Methods: This is a descriptive case series study, where a total of 145 cases with a history of recurrent thrombotic attacks, both venous and/or arterial, referred by physicians and gynaecologists of Military Hospitals (MH and...
متن کاملThrombophilia, clinical factors, and recurrent venous thrombotic events.
CONTEXT Data on the recurrence rate of venous thrombotic events and the effect of several risk factors, including thrombophilia, remain controversial. The potential benefit of screening for thrombophilia with respect to prophylactic strategies and duration of anticoagulant treatment is not yet known. OBJECTIVES To estimate the recurrence rate of thrombotic events in patients after a first thr...
متن کاملAntiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio
Background: There are very limited prospective data on the significance of persistent antiphospholipid antibodies (aPL) and recurrent thrombo-occlusive events (TOEs). We investigated the prognostic value of (1) 2 newer aPL assays, (2) an aPL portfolio and (3) persistent aPL positivity following stroke. Methods: A total of 1,770 subjects from the APASSWARSS study underwent further aPL testing fo...
متن کاملAntiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio.
BACKGROUND There are very limited prospective data on the significance of persistent antiphospholipid antibodies (aPL) and recurrent thrombo-occlusive events (TOEs). We investigated the prognostic value of (1) 2 newer aPL assays, (2) an aPL portfolio and (3) persistent aPL positivity following stroke. METHODS A total of 1,770 subjects from the APASS-WARSS study underwent further aPL testing f...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Korean Journal of Internal Medicine
سال: 2012
ISSN: 1226-3303,2005-6648
DOI: 10.3904/kjim.2012.27.2.232